Transient P-cadherin expression in radiation proctitis; a model of mucosal injury and repair

被引:15
作者
Hardy, RG
Brown, RM
Miller, SJ
Tselepis, C
Morton, DG
Jankowski, JAZ
Sanders, DSA
机构
[1] Univ Birmingham, Dept Surg, Clin Res Inst, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Dept Med, Birmingham B15 2TH, W Midlands, England
[3] Univ Hosp Birmingham, Dept Cellular Pathol, Birmingham, W Midlands, England
关键词
cadherin; radiation; proctitis; injury; repair;
D O I
10.1002/path.1092
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Morphology at both cellular and glandular levels in the colon is dependent to an extent on cell-cell adhesion mediated by cadherin-catenin complexes. Alterations in the expression of E-eadherin. the cadherin normally present in colon, have been shown to be implicated in tissue ;remodelling within the gastrointestinal tract. Furthermore, it has previously been shown that P-cadherin. normally present only in stratified epithelia and placenta, is expressed in colitis and during neoplastic change in the colon. The morphological features of mucosal injury induced by pre-operative radiotherapy in the non-neoplastic rectal mucosa were studied in patients with rectal adenocarcinoma. Three characteristic phases of radiation proctitis Acre defined on histological grounds (acute injury, and early and late regenerative phases) essentially correlating with the time interval between radiotherapy and surgery, such features were mirrored by alterations in cadherin-catenin expression and localization in rectal crypts. On immunohistochemistry and western blotting. P-cadherin was highly expressed in the acute injury and early regenerative phases, with a decreased level of expression during late regeneration. E-cadherin and associated catenins were translocated from membrane to cytoplasm in degenerating crypts, with return of normal membranous expression in regenerating crypts. In conclusion, radiation-induced proctitis represents an in vivo model of mucosal injury and regeneration and provides a valid model in which to study events during epithelial injury and repair. Altered cadherin expression, in particular transient aberrant P-cadherin expression, is intimately associated with these processes. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 25 条
[1]  
HABOUBI NY, 1988, AM J GASTROENTEROL, V83, P1140
[2]   Aberrant P-cadherin expression is an early event in hyperplastic and dlysplastic transformation in the colon [J].
Hardy, RG ;
Tselepis, C ;
Hoyland, J ;
Wallis, Y ;
Pretlow, TP ;
Talbot, I ;
Sanders, DSA ;
Matthews, G ;
Morton, D ;
Jankowski, JAZ .
GUT, 2002, 50 (04) :513-519
[3]   Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β [J].
Hart, MJ ;
de los Santos, R ;
Albert, IN ;
Rubinfeld, B ;
Polakis, P .
CURRENT BIOLOGY, 1998, 8 (10) :573-581
[4]   Identification of c-MYC as a target of the APC pathway [J].
He, TC ;
Sparks, AB ;
Rago, C ;
Hermeking, H ;
Zawel, L ;
da Costa, LT ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1998, 281 (5382) :1509-1512
[5]  
HIRAI Y, 1989, DEVELOPMENT, V105, P2271
[6]   EFFECT OF X-IRRADIATION ON THE RECTUM OF THE RAT [J].
HUBMANN, FH .
BRITISH JOURNAL OF RADIOLOGY, 1981, 54 (639) :250-254
[7]   Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin [J].
Ikeda, S ;
Kishida, S ;
Yamamoto, H ;
Murai, H ;
Koyama, S ;
Kikuchi, A .
EMBO JOURNAL, 1998, 17 (05) :1371-1384
[8]   p53-dependent radiation-induced crypt intestinal epithelial cells apoptosis is mediated in part through TNF-TNFR1 system [J].
Inagaki-Ohara, K ;
Yada, S ;
Takamura, N ;
Reaves, M ;
Yu, XH ;
Liu, ER ;
Rooney, I ;
Nicholas, S ;
Castro, A ;
Ware, CF ;
Green, DR ;
Lin, T .
ONCOGENE, 2001, 20 (07) :812-818
[9]   Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin [J].
Itoh, K ;
Krupnik, VE ;
Sokol, SY .
CURRENT BIOLOGY, 1998, 8 (10) :591-594
[10]  
Jakob T, 1998, J IMMUNOL, V160, P4067